In the financial world, there are many metrics shareholders can use to track their holdings. A duo of the most innovative are hedge fund and insider trading movement.
Keep Reading →
August 23 - News
Let's start with Digital Generation Inc (NASDAQ:DGIT).
Keep Reading →
August 19 - News
In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)'s extended phase 3 program for its inhaled insulin, Afrezza, is likely to produce ...
Keep Reading →
August 12 - News
Babe Ruth wasn't afraid to swing for the fences. That's how he became Major League Baseball's home run king for decades.
Keep Reading →
July 15 - News
Let's start with Fly Leasing Ltd (ADR) (NYSE:FLY).
Keep Reading →
July 15 - News
For the last few weeks, there has been a heated debate regarding the success or lack thereof from biotechnology company Amarin Corporation plc (ADR) (NASDAQ:AMRN)'s new product...
Keep Reading →
July 10 - News
"More means less." Amarin Corporation plc (ADR) (NASDAQ:AMRN) demonstrated this seemingly contradictory maxim today following its announcement of a new public offering.
Keep Reading →
July 9 - News
Today let's look at Passport Capital, founded by John Burbank in 2000 and known for combining macroeconomic analysis and fundamental research.
Keep Reading →
July 5 - Hedge Funds
While the analysis of peak sales and potential patient populations may be appealing to most, it costs a great deal of money to launch a new product with success.
Keep Reading →
July 1 - News
Just as we examine companies each week that may be rising past their fair value, we can also find companies potentially trading at bargain prices.
Keep Reading →
June 27 - News
Mark your calendars Amarin Corporation plc (ADR) (NASDAQ:AMRN) investors.
Keep Reading →
June 20 - News
Today, let's look at Moore Capital Management, managed by billionaire Louis Moore Bacon.
Keep Reading →
June 20 - Hedge Funds
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has recently launched its primary product candidate Vascepa into the market.
Keep Reading →
June 10 - News
AstraZeneca plc (ADR) (NYSE:AZN) announced the acquisition of Omthera Pharmaceuticals Inc (NASDAQ:OMTH), a company that went public just last month (April 11).
Keep Reading →
June 10 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Keep Reading →
June 10 - News
To the average investor, there are plenty of methods shareholders can use to monitor their holdings. A pair of the most useful are hedge fund and insider trading interest.
Keep Reading →
June 3 - News
It has been a rough year for Amarin Corporation plc (ADR) (NASDAQ:AMRN) and its long-term investors.
Keep Reading →
June 3 - News
The biotechnology sector is rapidly evolving, and what was a near-guarantee of success of getting a drug approved by the Food and Drug Administration 10 years ago is no longer...
Keep Reading →
June 3 - News
At the moment, there are a multitude of metrics investors can use to analyze their holdings. A duo of the most under-the-radar are hedge fund and insider trading activity.
Keep Reading →
May 31 - News
We've been speculating for almost a year that Amarin Corporation plc (ADR) (NASDAQ:AMRN) would be purchased by AstraZeneca plc (ADR) (NYSE:AZN).
Keep Reading →
May 29 - News
Amarin Corporation plc (ADR) (NASDAQ:AMRN) was in 19 hedge funds' portfolio at the end of March.
Keep Reading →
May 28 - News
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has been struggling a lot lately as retail channel prescription data for its EPA capsule Vascepa imply that the drug is starting to ...
Keep Reading →
May 28 - News
The company announced Tuesday after the close that it had set up an accelerated share repurchase agreement with Goldman Sachs Group, Inc.
Keep Reading →
May 24 - News
Leerink Swann reissued their outperform rating on shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN) in a research report released on Thursday morning, Stock Ratings Network...
Keep Reading →
May 13 - News
A study published in The New England Journal of Medicine testing omega-3 fatty acids -- commonly found in fish oil -- in patients with risk factors for cardiovascular disease ...
Keep Reading →
May 13 - News
Amarin Corporation plc (ADR) (NASDAQ:AMRN) was in 18 hedge funds' portfolio at the end of the fourth quarter of 2012.
Keep Reading →
May 9 - News
Editor's Note: Related tickers: JPMorgan Chase & Co.
Keep Reading →
May 3 - News
It’s not just about offering a better drug, but it’s also about launching it at the right time in the market.
Keep Reading →
April 28 - News
Editor's Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl ...
Keep Reading →
April 23 - News
Editor's Note: Related tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), Netflix, Inc. (NASDAQ:NFLX), Caesars Entertainment Corp (NASDAQ:CZR), Coach, Inc.
Keep Reading →
April 23 - News
Editor's Note: Related Tickers: Wal-Mart Stores, Inc.
Keep Reading →
April 18 - News
Amarin Corporation plc (ADR) (NASDAQ:AMRN) was in 18 hedge funds' portfolio at the end of December.
Keep Reading →
March 30 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 27 - News
Some stocks take a pounding, but there's usually what they call a dead-cat bounce.
Keep Reading →
March 25 - News
Sequester or no sequester, the folks at the Food and Drug Administration look to be quite busy in 2013.
Keep Reading →
March 25 - News
Today, let's look at Passport Capital, which was founded by John Burbank in 2000 and known for combining macroeconomic analysis and fundamental research.
Keep Reading →
March 20 - Hedge Funds
Last year, a number of drugs received FDA approval.
Keep Reading →
March 14 - News
As cardinals gather to elect a new pope, the conclave uses a smokestack to communicate the deliberations.
Keep Reading →
March 14 - News
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched...
Keep Reading →
March 6 - News
The last year has been a stellar one for the biotechnology industry.
Keep Reading →
February 26 - News
All throughout Wall Street we keep hearing about Amarin Corporation plc (ADR) (NASDAQ:AMRN) being bought out by some type of Big Pharma company in the future. It's all rumors...
Keep Reading →
February 22 - News
OraSure Technologies, Inc. (NASDAQ:OSUR) announced its fourth-quarter results after the market closed on Wednesday.
Keep Reading →
February 9 - News
Today, let's look at Tocqueville Asset Management, which is a portfolio manager with a contrarian bent, believing that "the best investment results over time are achieved outside...
Keep Reading →
February 6 - Hedge Funds